Eli Lilly is facing $165 million in charges and development milestones from the U.S. Securities and Exchange Commission (SEC). The charges come from several in-process research and development projects acquired outside of a business combination.

The U.S. Securities and Exchange Commission filed insider trading charges against Usama Malik, the former chief financial officer of Immunomedics Inc. 

After a year-long delay due to Covid-19, Theranos founder and CEO Elizabeth Holmes headed to court on Sept. 8 to face multiple criminal fraud charges that could land the former billionaire in prison for more than a decade.

DaVita and the dialysis provider’s former CEO Kent Thiry were indicted by a federal grand jury in Denver on charges they conspired with competitors not to hire each other’s key employees, the U.S. Justice Department said on July 15.

Regeneron Pharmaceuticals said the company will vigorously defend federal charges of being involved in a kickback scheme to bolster sales of the blockbuster macular degeneration drug Eylea.

The U.S. Securities and Exchange Commission leveled charges at a former Sangamo Therapeutics executive and others for an insider-trading scheme that netted more than $1.5 million in “illegal profits.”